Buy Tocira 400mg Tocilizumab

Tocira 400mg (Tocilizumab) is an injectable medication used to reduce inflammation in conditions like rheumatoid arthritis and cytokine release syndrome. This 400mg/20ml vial form is commonly prescribed for immune-mediated disorders. Find reliable pharmaceutical options for managing inflammatory responses. Short-term relief for chronic inflammatory conditions.

Strength

400mg/20ml

Manufacturer / TM Owner

Hetero Biopharma Limited

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Uses / Indications

Tocira 400mg is primarily used to treat moderate to severe rheumatoid arthritis in adults who haven’t responded well to other therapies. It’s also prescribed for cytokine release syndrome, a serious immune reaction that can occur after certain cancer treatments. Patients with giant cell arteritis or polyarticular juvenile idiopathic arthritis may also benefit from this medication. This drug works by blocking specific proteins that trigger inflammation.

Side Effects

Tocira 400mg helps reduce joint pain, swelling, and stiffness associated with inflammatory conditions over time. Many patients experience improved mobility and daily function as inflammation subsides. Some may notice a gradual reduction in fatigue and overall disease activity. Individual responses vary based on condition and treatment duration.

Precautions & Warnings

Store Tocira 400mg vials in a refrigerator between 2°C and 8°C and protect from light. Do not freeze or shake the vial. Always check the solution for particles or discoloration before use. Use within the recommended timeframe after opening and follow healthcare provider instructions for disposal. Keep out of reach of children.

Avoid Interactions

Tocira 400mg may interact with other immunosuppressants, increasing infection risk. Live vaccines should be avoided during treatment due to reduced immune response. Certain medications, including some biologics and strong CYP3A4 inhibitors, may affect how Tocira works. Always inform your healthcare provider about all medications being taken.

References

Frequently Asked Questions

Tocira 400mg is used to treat inflammatory conditions like rheumatoid arthritis and cytokine release syndrome.

Store vials refrigerated between 2°C and 8°C, protected from light, and do not freeze.

Common effects may include injection site reactions, headache, or increased cholesterol levels.

Yes, Tocira 400mg contains Tocilizumab, a biologic drug that targets specific immune proteins.

Patients with active infections or known hypersensitivity to Tocilizumab should avoid this medication.

Published by GNH India Pharmaceuticals Limited

Last updated: 18 May 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.